Characterization of Macroprolactinemia
Sponsor
Kansai Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT00436111
Collaborator
(none)
1
23
Study Details
Study Description
Brief Summary
The purpose of this study is to clarify the nature of macroprolactin which has recently been highlighted because of the high prevalence and a diagnostic pitfall of hyperprolactinemia. The results of this study are beneficial for the patients to whom unnecessary medications and unnecessary radiological examinations have been performed.
We used the remained serum samples taken for routine prolactin determination during the past several years. Since the blood was basically taken to examine the causes of hyperprolactinemia and only remained serum samples were used for this study, the Ethics Committee of Kobe City General Hospital judged that it was not required to obtain approval number.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Retrospective
Study Start Date
:
Jan 1, 2005
Study Completion Date
:
Dec 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Clinical diagnosis of hyperprolactinemia
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Kansai Medical University | Osaka | Japan | 570-8506 |
Sponsors and Collaborators
- Kansai Medical University
Investigators
- Study Chair: Naoki Hattori, M.D., Ph.D., Department of Pharmacology, Kansai Medical University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00436111
Other Study ID Numbers:
- KK-2007-1
First Posted:
Feb 16, 2007
Last Update Posted:
Feb 16, 2007
Last Verified:
Feb 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: